Tower Research Capital (TRC)’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.9K | Buy |
7,133
+3,577
| +101% | +$13.5K | ﹤0.01% | 3487 |
|
|
2025
Q1 | $16.1K | Buy |
3,556
+2,020
| +132% | +$9.15K | ﹤0.01% | 3182 |
|
|
2024
Q4 | $10.9K | Sell |
1,536
-16,018
| -91% | -$113K | ﹤0.01% | 3773 |
|
|
2024
Q3 | $143K | Buy |
17,554
+6,228
| +55% | +$50.7K | ﹤0.01% | 1941 |
|
|
2024
Q2 | $72.4K | Buy |
11,326
+10,525
| +1,314% | +$67.3K | ﹤0.01% | 2824 |
|
|
2024
Q1 | $6.03K | Sell |
801
-11,217
| -93% | -$84.5K | ﹤0.01% | 4445 |
|
|
2023
Q4 | $111K | Buy |
12,018
+8,900
| +285% | +$82.4K | ﹤0.01% | 2572 |
|
|
2023
Q3 | $31.6K | Buy |
3,118
+1,942
| +165% | +$19.7K | ﹤0.01% | 2978 |
|
|
2023
Q2 | $14.7K | Sell |
1,176
-188
| -14% | -$2.35K | ﹤0.01% | 3655 |
|
|
2023
Q1 | $16K | Buy |
1,364
+159
| +13% | +$1.87K | ﹤0.01% | 3697 |
|
|
2022
Q4 | $13K | Sell |
1,205
-4,635
| -79% | -$50K | ﹤0.01% | 3608 |
|
|
2022
Q3 | $57K | Sell |
5,840
-15,892
| -73% | -$155K | ﹤0.01% | 3038 |
|
|
2022
Q2 | $315K | Buy |
21,732
+20,335
| +1,456% | +$295K | 0.01% | 1446 |
|
|
2022
Q1 | $36K | Buy |
1,397
+212
| +18% | +$5.46K | ﹤0.01% | 2981 |
|
|
2021
Q4 | $47K | Sell |
1,185
-2,543
| -68% | -$101K | ﹤0.01% | 2808 |
|
|
2021
Q3 | $187K | Buy |
3,728
+2,746
| +280% | +$138K | ﹤0.01% | 1883 |
|
|
2021
Q2 | $55K | Sell |
982
-2,748
| -74% | -$154K | ﹤0.01% | 2947 |
|
|
2021
Q1 | $174K | Buy |
3,730
+1,992
| +115% | +$92.9K | ﹤0.01% | 2135 |
|
|
2020
Q4 | $76K | Sell |
1,738
-28,339
| -94% | -$1.24M | ﹤0.01% | 2625 |
|
|
2020
Q3 | $1.1M | Buy |
30,077
+25,682
| +584% | +$940K | 0.01% | 899 |
|
|
2020
Q2 | $128K | Buy |
+4,395
| New | +$128K | 0.01% | 2229 |
|
|
2020
Q1 | – | Sell |
-659
| Closed | -$23K | – | 3390 |
|
|
2019
Q4 | $23K | Buy |
659
+464
| +238% | +$16.2K | ﹤0.01% | 1829 |
|
|
2019
Q3 | $7K | Buy |
+195
| New | +$7K | ﹤0.01% | 3140 |
|